Completed PHASE4 INTERVENTIONAL 2-arm NCT00701285

South Korean Pitavastatin Heart Failure Study (SAPHIRE)

A Prospective, Randomized, Two Group Comparison Study to Evaluate the Effect of Statin on Heart Function in Patients With Chronic Ischemic Heart Failure.

Sponsor: JW Pharmaceutical

Conditions Chronic Heart Failure

Interventions pitavastatin pravastatin

Updated 6 times since 2017 Last updated: May 12, 2014 Started: Jul 31, 2008 Primary completion: May 31, 2013 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00701285, this PHASE4 trial focuses on Chronic Heart Failure and remains completed. Sponsored by JW Pharmaceutical, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

JW Pharmaceutical

Data source: JW Pharmaceutical

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea